Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Neuropharmacology. 2013 Oct 28;77:10.1016/j.neuropharm.2013.10.010. doi: 10.1016/j.neuropharm.2013.10.010

Figure 6.

Figure 6

Effects of YQA14 on basal level of locomotion and cocaine-induced behavioral sensitization. A: Pretreatment of YQA14 (12.5, 25 mg/kg, i.p., 20 min prior to each cocaine injection) did not produce a statistically significant inhibition on acquisition of cocaine-induced locomotor sensitization. Repeated administration of YQA14 (25 mg/kg) alone also failed to alter basal levels of locomotion. B: A single injection of YQA 14 (12.5, 25 mg/kg, i.p.) significantly inhibited expression of cocaine-induced locomotor sensitization in rats 7 days after the last cocaine injection.